ADP

U.S. Migration Trends, New Valentine's Day Treats: 11 Stories from The Week That You Might Have Missed

Retrieved on: 
Friday, January 5, 2024
Drone, Risk, Fireworks, Pacific Northwest, Luke, Growth, ADP, Space Needle

NEW YORK, Jan. 5, 2024 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed.

Key Points: 
  • The winner is America's only National Champion.
  • The T-Mobile New Year's at the Needle extravaganza was the longest show in the event's 32-year history, stunning viewers with an 18-minute display.
  • ADP National Employment Report: Private Sector Employment Increased by 164,000 Jobs in December; Annual Pay was Up 5.4%
    "We're returning to a labor market that's very much aligned with pre-pandemic hiring," said Nela Richardson, chief economist, ADP.
  • "While wages didn't drive the recent bout of inflation, now that pay growth has retreated, any risk of a wage-price spiral has all but disappeared."

Human medicines European public assessment report (EPAR): Lynparza, olaparib, Date of authorisation: 16/12/2014, Revision: 24, Status: Authorised

Retrieved on: 
Friday, January 5, 2024
Marketing, Platinum, INN, Risk, HER2, Leukopenia, Heartburn, Woman, BRCA, Man, Nausea, DNA, Cancer, Neoplasm, Mutation, Pancreatic cancer, ADP, Prostate, Anatomy, Cell division, Cough, IIA, Diarrhea, Prostate cancer, HRD, Fatigue, Breast cancer, ATC, Platelet, Pancreas, Prednisone, Disease, Genome, Abdomen, Testosterone, PARP, Neutrophil, Bevacizumab, Appetite, Human, Anemia, Patient, Medical Subject Headings, Peritoneum, International, FIGO, Tubing (recreation), Neutropenia, Language, Castration, Dizziness, Thrombocytopenia, BRCA1, Gene, Tablet, Select, Time, Vomiting, Ovary, Prednisolone, X-ray, Ovarian cancer, Headache, BRCA2, European Medicines Agency, Indigestion, Periodic breathing, Birth control

Human medicines European public assessment report (EPAR): Lynparza, olaparib, Date of authorisation: 16/12/2014, Revision: 24, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Lynparza, olaparib, Date of authorisation: 16/12/2014, Revision: 24, Status: Authorised

ADP National Employment Report: Private Sector Employment Increased by 164,000 Jobs in December; Annual Pay was Up 5.4%

Retrieved on: 
Thursday, January 4, 2024
Growth, ADP, Face, Payroll, Employment, Risk

ROSELAND, N.J., Jan. 4, 2024 /PRNewswire/ -- Private sector employment increased by 164,000 jobs in December and annual pay was up 5.4 percent year-over-year, according to the December ADP® National Employment ReportTM produced by the ADP Research Institute® in collaboration with the Stanford Digital Economy Lab ("Stanford Lab").

Key Points: 
  • ROSELAND, N.J., Jan. 4, 2024 /PRNewswire/ -- Private sector employment increased by 164,000 jobs in December and annual pay was up 5.4 percent year-over-year, according to the December ADP® National Employment ReportTM produced by the ADP Research Institute® in collaboration with the Stanford Digital Economy Lab ("Stanford Lab").
  • The jobs report and pay insights use ADP's fine-grained anonymized and aggregated payroll data to provide a representative picture of the private-sector labor market.
  • The report details the current month's total private employment change, and weekly job data from the previous month.
  • Because the underlying ADP payroll databases are continuously updated, the report provides a high-frequency, near real-time measure of U.S. employment.

Satori Collective Completes Sale of 124-Suite Holiday Inn Express & Suites Alpharetta-Windward Parkway

Retrieved on: 
Tuesday, January 2, 2024
REIT, Lodging, Commercial Building & Real Estate, Construction & Property, Travel, Multimedia, Sale, Research, Acquisition, Eye, CIO, Innovation Way, Ameris Bank Amphitheatre, IHG, Growth, ADP, Hewlett-Packard, Environment, Hotel

Officials of Satori Collective, a real estate investment management firm focused primarily on hotel property investment, today announced the sale of the 124-suite Holiday Inn Express & Suites Alpharetta-Windward Parkway to Bukhari Group Hospitality.

Key Points: 
  • Officials of Satori Collective, a real estate investment management firm focused primarily on hotel property investment, today announced the sale of the 124-suite Holiday Inn Express & Suites Alpharetta-Windward Parkway to Bukhari Group Hospitality.
  • Satori achieved an approximate 24% internal rate of return and a 2x equity multiple through the sale.
  • View the full release here: https://www.businesswire.com/news/home/20240102173840/en/
    Officials of Satori Collective, a real estate investment management firm focused primarily on hotel property investment, today announced the sale of the 124-suite Holiday Inn Express & Suites Alpharetta-Windward Parkway (pictured) to Bukhari Group Hospitality.
  • (Photo: Business Wire)
    “We purchased this all-suite property in 2013 and quickly conducted a comprehensive, multi-million dollar, value-add renovation to re-flag the property to a Holiday Inn Express & Suites by IHG,” said Samir Yajnik, CIO, Satori Collective.

Human medicines European public assessment report (EPAR): Clopidogrel Krka, clopidogrel, Date of authorisation: 23/09/2009, Revision: 19, Status: Authorised

Retrieved on: 
Tuesday, January 2, 2024
Patient, Medical Subject Headings, Marketing, Acute coronary syndrome, Artery, European Commission, Agency, Moyamoya disease, INN, Risk, Platelet, ATC, Myocardial infarction, Bleeding, International, European, Blood, Language, Brain, Heart, Splenic infarction, Vascular disease, European Medicines Agency, Tablet, ADP, Select, Chest pain, Aspirin, Anatomy, Medicine, IIA, Atrial fibrillation, Medical device

Human medicines European public assessment report (EPAR): Clopidogrel Krka, clopidogrel, Date of authorisation: 23/09/2009, Revision: 19, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Clopidogrel Krka, clopidogrel, Date of authorisation: 23/09/2009, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Clopidogrel Taw Pharma (previously Clopidogrel Mylan), clopidogrel, Date of authorisation: 21/09/2009, Revision: 21, Status: Authorised

Retrieved on: 
Tuesday, January 2, 2024
Medical Subject Headings, Marketing, Acute coronary syndrome, Artery, Moyamoya disease, INN, Risk, ATC, Myocardial infarction, Bleeding, International, Blood, Language, Brain, Heart, TIA, Vascular disease, European Medicines Agency, Preventive healthcare, Tablet, ADP, Select, Chest pain, Aspirin, Patient, Anatomy, Medicine, IIA, Atrial fibrillation, Generic drug

Human medicines European public assessment report (EPAR): Clopidogrel Taw Pharma (previously Clopidogrel Mylan), clopidogrel, Date of authorisation: 21/09/2009, Revision: 21, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Clopidogrel Taw Pharma (previously Clopidogrel Mylan), clopidogrel, Date of authorisation: 21/09/2009, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Clopidogrel Viatris (previously Clopidogrel Taw Pharma), clopidogrel, Date of authorisation: 16/10/2009, Revision: 27, Status: Authorised

Retrieved on: 
Tuesday, January 2, 2024
Medical Subject Headings, Marketing, Acute coronary syndrome, Thrombolysis, Artery, Moyamoya disease, INN, Risk, ABCD2, ATC, Myocardial infarction, Bleeding, International, Blood, ASA, Brain, NIHSS, Language, Heart, TIA, Vitamin K, Vascular disease, Percutaneous coronary intervention, European Medicines Agency, VKA, Preventive healthcare, Tablet, ADP, Select, Chest pain, Aspirin, Patient, Anatomy, IIA, Atrial fibrillation, Generic drug

Human medicines European public assessment report (EPAR): Clopidogrel Viatris (previously Clopidogrel Taw Pharma), clopidogrel, Date of authorisation: 16/10/2009, Revision: 27, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Clopidogrel Viatris (previously Clopidogrel Taw Pharma), clopidogrel, Date of authorisation: 16/10/2009, Revision: 27, Status: Authorised

Harri Continues to Grow Award-Winning Team, Welcomes Quincy Valencia as SVP, Innovation

Retrieved on: 
Wednesday, December 13, 2023
Internet celebrity, RPO, HD Supply, The Home Depot, AMS, HR, Innovation, ISG, HCM, Product innovation, ADP, Senior, Management

Prior to Harri, Valencia was Vice President and Research Director – Human Capital Management Technology at Ventana Research, now part of ISG.

Key Points: 
  • Prior to Harri, Valencia was Vice President and Research Director – Human Capital Management Technology at Ventana Research, now part of ISG.
  • Valencia was recently shortlisted for 2023 Analyst of the Year by the Institute of Influencer and Analyst Relations for her work at Ventana.
  • Before becoming an analyst, Valencia spent four years at AMS, where she assumed the role of Vice President – Product Innovation.
  • We set out to change the employee experience for frontline workers through technology and succeeded,” said Harri CEO Luke Fryer.

Church Mutual® Appoints New Director to Its Board

Retrieved on: 
Tuesday, December 19, 2023
Consumer, Religion, Professional Services, Asset Management, Insurance, Marketing, Economics, Business administration, Voya Financial, Bachelor of Arts, Bachelor, VOYA, University, Human, Master of Business Administration, Columbia Business School, Novartis, Avis Budget Group, ADP, Saperstein, Management

She will replace Director Marsha Lindsay, who will retire from the Board in May 2024.

Key Points: 
  • She will replace Director Marsha Lindsay, who will retire from the Board in May 2024.
  • “I am excited to work with Church Mutual as a member of the Board of Directors,” said Saperstein.
  • “I look forward to using my background in customer experience to help fuel Church Mutual’s growth long into the future.”
    Saperstein is the chief customer experience officer at Voya Financial.
  • Previously, she was head of global strategy at Avis Budget Group, and also led strategy, business development and customer experience at ADP.

Concordia University Chicago Chooses to Expand Its Online Accelerated Degree Offerings in Partnership with Relearnit, Inc.

Retrieved on: 
Tuesday, December 19, 2023
Education, Training, Continuing, University, Online, Concordia University, Work, Family, Partnership, Learning, Business, Student, Doctor of Philosophy, College, CUC, Concordia University Chicago, ADP, Health administration, News, Management

Relearnit, Inc. (Relearnit) is pleased to expand its longstanding partnership with Concordia University Chicago (CUC) to include accelerated bachelor’s degree programs (ADP) in Healthcare Administration and Sports Management.

Key Points: 
  • Relearnit, Inc. (Relearnit) is pleased to expand its longstanding partnership with Concordia University Chicago (CUC) to include accelerated bachelor’s degree programs (ADP) in Healthcare Administration and Sports Management.
  • CUC’s ADP programs are designed with working adults in mind, allowing students to balance competing demands of work, study and family through an online course modality.
  • The ADP bachelor’s degrees also offer benefits such as flexible scheduling, regular access to instructors and online collaboration with classmates.
  • For more information about the newly expanded bachelor’s degree programs, as well as other online programs offered through CUC, please visit https://exsci.cuchicago.edu .